Mesenchymal stromal cells: a new tool against graft-versus-host disease?
about
Human Mesenchymal Stromal Cells from Different Sources Diverge in Their Expression of Cell Surface Proteins and Display Distinct Differentiation PatternsMesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantationMesenchymal Stromal Cells and Viral InfectionGraft-versus-host disease: why have we not made more progress?Mechanisms of mesenchymal stem/stromal cell functionHLA-G as a tolerogenic molecule in transplantation and pregnancy.Adipose-derived stromal cells promote allograft tolerance induction.Mesenchymal Stem Cell Lines Isolated by Different Isolation Methods Show Variations in the Regulation of Graft-versus-host Disease.Human umbilical cord and dental pulp-derived mesenchymal stem cells: biological characteristics and potential roles in vitro and in vivo.Could cancer and infection be adverse effects of mesenchymal stromal cell therapy?Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo.Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity.Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis.Prevention of graft-vs.-host diseaseOral chronic graft-versus-host disease: current pathogenesis, therapy, and researchSteroids Versus Steroids Plus Additional Agent in Frontline Treatment of Acute Graft-versus-Host Disease: A Systematic Review and Meta-Analysis of Randomized Trials.Application of MultiStem(®) Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease.Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation.Thinking out of the box--new approaches to controlling GVHD.Concise review: the bone marrow niche as a target of graft versus host disease.Mesenchymal stromal cells in the antimicrobial host response of hematopoietic stem cell recipients with graft-versus-host disease--friends or foes?The gap between the physiological and therapeutic roles of mesenchymal stem cells.Rationale for the potential use of mesenchymal stromal cells in liver transplantation.Methods of ex vivo expansion of human cord blood cells: challenges, successes and clinical implications.Novel approaches for preventing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Bone regeneration in the stem cell era: safe play for the patient?Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases.Novel strategies for improving hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation or intensive chemotherapy.Mesenchymal stromal cells and autoimmunity.In Vitro Evaluation of Scaffolds for the Delivery of Mesenchymal Stem Cells to WoundsGamma irradiation preserves immunosuppressive potential and inhibits clonogenic capacity of human bone marrow-derived mesenchymal stromal cells.Human Mesenchymal Stem Cell-Educated Macrophages Are a Distinct High IL-6-Producing Subset that Confer Protection in Graft-versus-Host-Disease and Radiation Injury Models.Human mesenchymal stem cells provide protection against radiation-induced liver injury by antioxidative process, vasculature protection, hepatocyte differentiation, and trophic effects.Therapeutic Efficacy of Fresh, Allogeneic Mesenchymal Stem Cells for Severe Refractory Feline Chronic Gingivostomatitis.Impact of human mesenchymal stromal cells on antifungal host response against Aspergillus fumigatus.Amyotrophic lateral sclerosis as a protein level, non-genomic disease: Therapy with S2RM exosome released molecules.Clinical potential of mesenchymal stem/stromal cell-derived extracellular vesicles.Amyotrophic lateral sclerosis as a protein level, non-genomic disease: Therapy with S2RM exosome released molecules.Mechanisms of Immune Suppression Utilized by Canine Adipose and Bone Marrow-Derived Mesenchymal Stem Cells.Influence of Immunogenicity of Allogeneic Bone Marrow Mesenchymal Stem Cells on Bone Tissue Engineering.
P2860
Q26771921-D1B41658-0913-4DAB-8054-1ACCEF870DE9Q26775513-EB543CC7-9EAE-4680-97EF-FC44A2EABF7DQ26796198-5352F479-ED00-478C-87FD-0BB937C18B6EQ27012940-3BCADD38-87C0-4ED8-B493-98C01752DB26Q28079649-E8DC2447-8D49-4E97-9D22-862D9946D3CDQ34038019-92853B14-D13E-4059-89F7-C32E7D04EBA8Q34601943-DBBB210D-B152-41D5-ACB7-895772F5E598Q34979429-54C4C073-034B-4AD5-821D-472501A3411FQ35201701-3DAE1056-38B4-45D5-9E68-062A66CA8003Q35205677-7B202F4C-B2A1-43CB-AE66-FE0A60EDD69EQ35224328-CC53B6BE-CFB4-438E-9A22-8E52D012B5ECQ36014986-21CD95C1-259F-4E21-A073-30E1B48F0618Q36045296-ED109CA1-F2E6-4185-974B-4C26CB45E4B6Q36431047-322E7187-8F9F-459D-97BE-48BD49095B17Q36579263-4751DEF7-BA16-4FFA-83E6-517BB9522286Q37302887-71056CCF-5D52-475E-B695-87BDF72F39D1Q38064454-14DF2AEC-716D-437B-9D10-C18F2A6D4830Q38105635-427F0E24-6197-40FF-AF06-DFCF819DC4A6Q38175862-8250C635-ACC3-4668-8390-E9A0961D9784Q38192559-30BF9FBC-3866-4EDA-B9DD-A6F3EF7FBD28Q38206879-E03747B0-75CF-49C9-BCB9-6A8B679F542AQ38215374-D632EE24-CA31-40FA-8187-A0796329385DQ38282065-AE568FF6-B51F-43BB-8C0E-B42CD96DDB96Q38658670-E5433717-771A-4CB9-86F4-A809F05F2B22Q38816505-0BCC1C56-0F80-4CC0-814E-A1791C74BC8FQ38941719-5ACE7833-DFE2-4930-947F-7375D84E1794Q39017821-EB33022C-2325-4316-9D8F-6CC782E5E5C2Q39031745-6F1EB025-B646-4CB9-B15C-CA11E43E6584Q39198564-C831A3BC-D201-4DE9-89AB-83CC309A840FQ42001107-F8A1D0ED-EDE6-42B8-AAD1-EBF042010741Q42360160-B5233876-EE14-43E7-97FD-EE181336FA3CQ42775866-794D2108-227B-427F-838C-06ED348138ACQ42793902-5FF14B8D-27F7-4258-98B3-931C84A8D5AAQ45947247-98245A1E-61DF-497F-AAFC-3EACAEB14A4AQ47098057-C2E60C11-1FD3-4A6A-B013-C36E12CD4EAFQ47169869-4DE42B60-2AF8-44FE-A415-3FFE11D1D949Q47191632-79F4C856-FADF-4C31-8465-ADB793034E98Q47193821-8B9500B5-FF47-4272-8895-CB8284A22A25Q51307397-5916A71C-CB99-4559-ADA6-566673533EE0Q53553421-5D338110-B16F-4A36-96EB-64776714C83C
P2860
Mesenchymal stromal cells: a new tool against graft-versus-host disease?
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Mesenchymal stromal cells: a new tool against graft-versus-host disease?
@ast
Mesenchymal stromal cells: a new tool against graft-versus-host disease?
@en
type
label
Mesenchymal stromal cells: a new tool against graft-versus-host disease?
@ast
Mesenchymal stromal cells: a new tool against graft-versus-host disease?
@en
prefLabel
Mesenchymal stromal cells: a new tool against graft-versus-host disease?
@ast
Mesenchymal stromal cells: a new tool against graft-versus-host disease?
@en
P2860
P1476
Mesenchymal stromal cells: a new tool against graft-versus-host disease?
@en
P2093
Frédéric Baron
P2860
P304
P356
10.1016/J.BBMT.2011.09.003
P577
2011-09-29T00:00:00Z